Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score

• Main Authors: Yongjiang Li (Author), Yangxun Pan (Author), Ximeng Lin (Author), Jingyu Hou (Author), Zili Hu (Author), Li Xu (Author), Zhongguo Zhou (Author), Yaojun Zhang (Author), Minshan Chen (Author), Dandan Hu (Author)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Background: There is not yet an effective marker in predicting the efficacy of immune checkpoint inhibitors (ICIs) in treating hepatocellular carcinoma (HCC) patients. The Gustave Roussy Immune Score (GRIm-Score) based on three objective variables, namely, neutrophil-to-lymphocyte ratio (NLR), serum...